Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the entire clinical development process from Phase I to Phase IV. Co. provides these services across a range of therapeutic areas. Co.'s suite of clinical development services includes, but is not limited to, the following: medical department, clinical trial management, data-driven feasibility, study start-up, patient recruitment and retention, clinical monitoring and pharmacovigilance. The MEDP stock yearly return is shown above.
The yearly return on the MEDP stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2018 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the MEDP annual return calculation with any dividends reinvested as applicable (on ex-dates).
|